spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Celera 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 21 Jul 2026
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2026
ProFound Therapeutics Appoints Ainslie Little as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2026
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2026
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA(R) Growth Opportunities and Regulatory Priorities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jun 2026
Celltaxis Names Co-Founder Eileen Heffernan as CEO to Accelerate Growth and Expand Leadership in Lymphatic Disease Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2026
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2026
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Interventional Neurosurgery Venture Capital
 HSMN NewsFeed - 2 Jun 2026
Altesa BioSciences Appoints Brett Haumann, MBBCh, MBA, to its Board of Directors and Gwen Skloot, MD, ATSF, as Senior Vice President for Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2026
Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 29 May 2026
SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership
Devices Surgery FDA
 HSMN NewsFeed - 28 May 2026
NOWDiagnostics Appoints Lisa Nibauer as Chief Executive Officer to Lead Next Phase of Innovation and Transformation
Diagnostics Personnel
 HSMN NewsFeed - 27 May 2026
Subtle Medical Receives FDA Clearance for SubtleHD(TM)(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software
Devices Radiology FDA
 HSMN NewsFeed - 26 May 2026
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
Devices Urology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2026
Peter Menziuso Named EVP and President, BD Interventional
Devices Interventional Personnel
 HSMN NewsFeed - 11 May 2026
Partner Therapeutics Announces FDA Approval of BIZENGRI(R) (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 May 2026
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 May 2026
Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
Devices Oncology
 HSMN NewsFeed - 30 Apr 2026
Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer(TM) Implant
Devices Orthopaedic
 HSMN NewsFeed - 30 Apr 2026
Photon Raises $16M Series A to Give Patients Control Over Their Prescriptions and Bring Transparency to Pharmacy
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Apr 2026
Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System
Devices Surgery Regulatory
 HSMN NewsFeed - 16 Apr 2026
Harbour BioMed Appoints Dr. Adam Zong as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Devices Neurology Monitoring Venture Capital
 HSMN NewsFeed - 13 Apr 2026
Lilly's Jaypirca (Pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2026
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2026
Ziptek Introduces Breakthrough ZipE(R) Biolock(TM) Technology, Redefining Tissue Repair Worldwide
Devices Orthopaedic Surgery
 HSMN NewsFeed - 8 Apr 2026
Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company's Pioneering Work in Mitochondrial Medicine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2026
Tetrous(R) Announces Completion of First Cases with EnFix ACL(TM) for ACL Reconstruction
Devices Orthopaedic
 HSMN NewsFeed - 6 Apr 2026
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2026
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 31 Mar 2026
Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2026
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2026
Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2026
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
Devices Interventional Oncology
 HSMN NewsFeed - 19 Mar 2026
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2026
IsomAb appoints Dr Philip Brainin as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2026
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2026
ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Mar 2026
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2026
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
Devices Interventional
 HSMN NewsFeed - 3 Mar 2026
Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 27 Feb 2026
Norgine Welcomes Positive CHMP Opinion Recommending Approval of Mavorixafor in the European Union for WHIM Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Feb 2026
Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
Devices Radiology Venture Capital
 HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 18 Feb 2026
Synchrony Medical Secures $5M Funding to Fuel Commercial Expansion of its At-Home Airway Clearance Device for Chronic Respiratory Disease
Devices Venture Capital
 HSMN NewsFeed - 6 Feb 2026
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jan 2026
FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care
Devices Wound Care FDA
 HSMN NewsFeed - 29 Jan 2026
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing
Devices Endocrinology Personnel
 HSMN NewsFeed - 27 Jan 2026
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
Biopharmaceuticals
 HSMN NewsFeed - 22 Jan 2026
Resolve M Therapeutics Exits From Stealth
Biopharmaceuticals
 HSMN NewsFeed - 19 Jan 2026
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Jan 2026
Haemonetics Acquires Vivasure Medical Limited
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2026
Seasoned Biotherapeutics Leader Thomas J. Farrell Joins NanoSyrinx as CEO to Advance Nanosyringe-enabled Intracellular Medicines
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2026
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jan 2026
SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO
Devices Radiology Acquisitions Personnel
 HSMN NewsFeed - 29 Dec 2025
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Dec 2025
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2025
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
Diagnostics
 HSMN NewsFeed - 15 Dec 2025
Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Dec 2025
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2025
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Nov 2025
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
Devices Cardiology Personnel
 HSMN NewsFeed - 20 Nov 2025
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
Diagnostics Regulatory
 HSMN NewsFeed - 13 Nov 2025
HAPPE Spine Reaches 1,000 Patients with the INTEGRATE(R)-C Interbody Fusion System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 10 Nov 2025
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review
Diagnostics Personnel
 HSMN NewsFeed - 7 Nov 2025
Laborie Announces Agreement to Acquire the JADA(R) System from Organon
Devices Acquisitions
 HSMN NewsFeed - 6 Nov 2025
Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix(R) Spinal System
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 4 Nov 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Oct 2025
CustoMED Announces $6M Funding to Scale AI-Powered 3D Printed Solutions for Orthopedic Surgery
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 28 Oct 2025
ViCentra Strengthens Leadership Team to Accelerate Growth
Devices Endocrinology Drug Delivery Personnel
 HSMN NewsFeed - 27 Oct 2025
Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Devices Interventional Neurology
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2025
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2025
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2025
Alcresta Therapeutics Expands Executive Leadership to Drive Strategic Initiatives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2025
Revance Expands Leadership Team with Key Executive Appointments
Devices Dermatology Personnel
 HSMN NewsFeed - 30 Sep 2025
Natus Acquires Holberg EEG, Expanding Innovation in Neurodiagnostic AI Solutions
Devices Diagnostics Neurology Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2025
TSC Life Receives FDA 510(K) Clearance for Fluido(R) AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
Devices FDA
 HSMN NewsFeed - 18 Sep 2025
J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2025
Amber Implants Secures FDA 510(k) Clearance for VCFix(R) Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 16 Sep 2025
Roche Receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App Integration, Offering an Enhanced Diabetes Management Experience
Devices Monitoring Regulatory
 HSMN NewsFeed - 8 Sep 2025
FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan(R)) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials
Diagnostics FDA
 HSMN NewsFeed - 2 Sep 2025
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Aug 2025
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
Devices Orthopaedic Personnel
 HSMN NewsFeed - 19 Aug 2025
Medtronic Announces Board Appointments and Shareholder Value Creation Initiatives to Advance Strategic Priorities
Devices Personnel
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2025
Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
Biopharmaceuticals
 HSMN NewsFeed - 11 Aug 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Jul 2025
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 23 Jul 2025
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas(TM) Wearable Injector Technology for Biologic Drugs
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 21 Jul 2025
AKSM/Oncology Selects RayCare and RayStation For a New Cancer Center
Devices Oncology
 HSMN NewsFeed - 15 Jul 2025
GT Medical Technologies Completes Final Close of Company's Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Devices Neurosurgery Oncology Venture Capital
 HSMN NewsFeed - 14 Jul 2025
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Jul 2025
Tomoverse Imaging Inc. Announces Closing of $5 Million Dollar Seed Funding Round Led by Strategic Canadian Family Office
Devices Radiology Cardiology Venture Capital
 HSMN NewsFeed - 2 Jul 2025
Moon Surgical Receives FDA Clearance for Maestro(TM) Connectivity and Predetermined Change Control Plan for AI-Powered ScoPilot(R)
Devices Surgery FDA
 HSMN NewsFeed - 1 Jul 2025
Q'Apel Medical Appoints Stewart Strong as President and Chief Executive Officer
Devices Neurology Interventional Personnel
 HSMN NewsFeed - 30 Jun 2025
Oncolytics Biotech(R) Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jun 2025
Avivomed Names Dan Brounstein as Next Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Jun 2025
Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jun 2025
RayStation Used for Pioneering Clinical Milestone at Helsinki University Hospital - First Treatment with Accelerator-Based BNCT in Europe
Devices Oncology
 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Jun 2025
Spineart Announces Full-Market Launch of SCARLET(R) AC-Ti Secured Anterior Cervical Cage in the US
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2025
Diakonos Oncology Closes $20 Million Financing to Accelerate Phase 2 Glioblastoma Clinical Development Program and Expand Use of Innovative Dendritic Cell Platform for Studies in Other Indications
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 May 2025
Medtronic Announces Intent to Separate Diabetes Business
Devices Endocrinology Drug Delivery
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2025
Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy
Devices Oncology
 HSMN NewsFeed - 12 May 2025
Ted Myles Joins Cellarity as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2025
RaySearch releases RayStation v2025
Devices Oncology Product Launch
 HSMN NewsFeed - 28 Apr 2025
IceCure Exhibits ProSense(R) & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
Devices Oncology
 HSMN NewsFeed - 22 Apr 2025
LifeSignals launches UbiqVue(TM) Holter System in partnership with UltraLinQ at Heart Rhythm 2025
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 18 Apr 2025
Leidos Invests $10 Million in AI Disease Detection with University of Pittsburgh
Diagnostics
 HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital
 HSMN NewsFeed - 15 Apr 2025
hellocare.ai Raises $47M to Accelerate AI-Assisted Virtual Care and Transform Hospital Rooms into Smart, Connected Care Environments
Devices Venture Capital
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Apr 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Mar 2025
Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2025
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2025
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical
Devices Orthopaedic Licensing
 HSMN NewsFeed - 10 Mar 2025
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2025
The Chinese Carbon Ion Center Heyou Hospital Selects RayStation
Devices Oncology
 HSMN NewsFeed - 4 Mar 2025
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
Devices Neurology Venture Capital
 HSMN NewsFeed - 20 Feb 2025
Valencia Technologies Announces Strategic Investment of up to $35 Million and Appointment of James D. Surek as Chief Executive Officer
Devices Personnel Venture Capital
 HSMN NewsFeed - 18 Feb 2025
Oncolytics Biotech(R) Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Feb 2025
Neuvotion Receives FDA Clearance for NeuStim(TM) Providing Non-Invasive, High-Resolution Stimulation for the Hand After Stroke or Spinal Cord Injury
Devices Neurology FDA
 HSMN NewsFeed - 20 Jan 2025
MicroAire Completes Acquisition of NEOSYAD
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jan 2025
FindReps(R) App Update Features AI-Assisted SmartProfiles(TM)
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Dec 2024
Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2024
AnX Robotica awarded Gastrointestinal Endoscopy Products agreement with Premier, Inc.
Devices Gastroenterology Group Purchasing
 HSMN NewsFeed - 22 Nov 2024
Bioretec Signed a New Sales and Distribution Agreement to Accelerate the Commercialization of RemeOs(TM) Trauma Screw in the U.S. Civilian Hospital Market
Devices Orthopaedic Distribution
 HSMN NewsFeed - 8 Nov 2024
FDA Advisory Panel Votes in Favor of IceCure's ProSense(R) Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 31 Oct 2024
Evommune Announces $115 Million Series C Financing to Accelerate Advancement of Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2024
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2024
Mari Hoidal joins Avails Medical as Vice President of Marketing
Diagnostics Personnel
 HSMN NewsFeed - 10 Oct 2024
Rivermark Medical Closes $30 Million Series C Financing to Advance Development of Flostent(TM) System for Benign Prostatic Hyperplasia
Devices Urology Venture Capital
 HSMN NewsFeed - 9 Oct 2024
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
Devices Neurology Venture Capital
 HSMN NewsFeed - 26 Sep 2024
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Devices Oncology
 HSMN NewsFeed - 21 Aug 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2024
Pathalys Pharma Secures $105 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 14 Aug 2024
IceCure's ProSense(R) Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of Surgery
Devices Oncology
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 11 Jul 2024
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo(R) (vadadustat) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2024
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Devices Diagnostics Product Launch
 HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
Devices Venture Capital
 HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2024
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI(R) Miniature Handheld Robotic System for Total Knee Arthroplasty
Devices Surgery Distribution
 HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jun 2024
Moon Surgical receives second FDA clearance, covering its commercial Maestro(TM) Robotic Surgery System
Devices Surgery FDA
 HSMN NewsFeed - 30 May 2024
US FDA Awards Supplemental Orphan Drug Designation to Survaxm to Now Include Treatment of Malignant Glioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 May 2024
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Devices Diagnostics Cardiology FDA
 HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics
 HSMN NewsFeed - 23 May 2024
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 May 2024
Rad AI Closes $50 Million to Empower Physicians with AI
Devices Radiology Venture Capital
 HSMN NewsFeed - 30 Apr 2024
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 15 Apr 2024
Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors
Devices Orthopaedic Personnel
 HSMN NewsFeed - 4 Apr 2024
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Devices Oncology Personnel
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2024
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices(TM) Cardiopulmonary Management (CPM) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2024
Baird Medical Expands Presence in the United States
Devices Oncology Personnel
 HSMN NewsFeed - 27 Feb 2024
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Feb 2024
Study Using IceCure's ProSense(R) Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
Devices Oncology
 HSMN NewsFeed - 21 Feb 2024
Zynex Introduces New Products
Devices Orthopaedic Pain Management Product Launch
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 13 Feb 2024
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel
 HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jan 2024
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
Diagnostics Product Launch
 HSMN NewsFeed - 29 Jan 2024
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class
Devices Oncology
 HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Jan 2024
NeoImmuneTech Welcomes a New President for its Development and Business
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jan 2024
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2023
FeelTect secures €1.5 million investment for connected wound treatment technology
Devices Wound Care Monitoring Venture Capital
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 11 Dec 2023
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2023
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity(TM) Acute Infection and Sepsis Test System
Diagnostics FDA
 HSMN NewsFeed - 22 Nov 2023
Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 12 Oct 2023
Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc(R) Match-the-Disc(TM) Cervical and Lumbar Total Disc Replacement Systems
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 11 Oct 2023
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2023
Rarebase Names Chris Moxham as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2023
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2023
2,500 Procedures Completed in U.S. with Centinel Spine's prodisc(R) C Vivo and prodisc C SK Cervical Total Disc Replacement System, Less than One Year After Limited Launch
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 26 Sep 2023
Abyrx Receives FDA Clearance for MONTAGE(R) Settable Bone Putty for Use in Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 25 Sep 2023
Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
Diagnostics Venture Capital
 HSMN NewsFeed - 20 Sep 2023
VerImmune Inc. announces over $3M Additional Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Sep 2023
Day Zero Diagnostics Announces Completion of $16M Financing Round
Diagnostics Venture Capital
 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2023
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 7 Sep 2023
Silony Medical acquires Centinel Spine's Global Fusion Business
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 6 Sep 2023
Convergent Therapeutics Expands Leadership Team with the Appointments of Neil Bander, MD. as Chief Scientific Officer, Eric M. Sullivan as Chief Financial Officer, and Dimitris Voliotis, MD. as Senior Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Aug 2023
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America
Devices Personnel
 HSMN NewsFeed - 22 Aug 2023
Zimmer Biomet Announces Leadership Transition
Devices Orthopaedic Personnel
 HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2023
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 9 Aug 2023
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Aug 2023
Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2023
iotaMotion Completes $12M Series A Raise to Accelerate Commercial Expansion of iotaSOFT(R) Insertion System
Devices Surgery Venture Capital
 HSMN NewsFeed - 25 Jul 2023
Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
Diagnostics FDA
 HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2023
PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovation
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2023
MEDICAL IP Received US FDA 510(k) Clearance for DeepCatch, AI Software for Whole-Body Composition CT Quantification
Devices Radiology FDA
 HSMN NewsFeed - 15 Jun 2023
RaySearch signs agreement with Shinva for large order in China
Devices Oncology
 HSMN NewsFeed - 25 May 2023
Medtronic to acquire wearable insulin patch maker EOFlow
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2023
RayCare is interoperable with Varian TrueBeam
Devices Oncology
 HSMN NewsFeed - 10 May 2023
Sobi to Acquire CTI BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2023
Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections
Devices FDA
 HSMN NewsFeed - 3 May 2023
Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Apr 2023
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2023
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Devices Neurology FDA
 HSMN NewsFeed - 30 Mar 2023
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
Devices Orthopaedic FDA
 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Mar 2023
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Devices Neurosurgery Personnel
 HSMN NewsFeed - 23 Mar 2023
New evidence demonstrates Smith & Nephew's COBLATION(TM) Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
Devices Surgery
 HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Mar 2023
Shoulder Innovations Announces Oversubscribed $42 million Series D Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2023
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 8 Feb 2023
Ostial Corp Closes $7.5M Series C Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 1 Feb 2023
Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Jan 2023
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2023
Mantra Bio Raises $9 Million in Series A-2 Financing to Advance Development of Lead Targeted Exosome Therapeutics Program
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 4 Jan 2023
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Dec 2022
Curate Biosciences Announces David Backer as Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 15 Dec 2022
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
Devices Cardiology Distribution
 HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Dec 2022
STORM Therapeutics announces closing of USD $30M Series B financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Dec 2022
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
Diagnostics Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel
 HSMN NewsFeed - 16 Nov 2022
Haystack Oncology Launches with $56 Million in Series A Financing to Accelerate Adoption of Post-Op Cancer Detection Technology and Optimize Cancer Therapy Monitoring and Treatment
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Nov 2022
Ibex Medical Analytics Secures $10M Funding from Kreos Capital
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 9 Nov 2022
Odyssey Therapeutics Expands Management Team with Key Appointments in Research Development and Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Nov 2022
Cordis promotes Alan Tsai as GM Greater China
Devices Interventional Personnel
 HSMN NewsFeed - 3 Nov 2022
Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Oct 2022
Medtronic Announces Intention to Separate its Combined Patient Monitoring and Respiratory Interventions Businesses
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 19 Oct 2022
Immunovia Announces Executive Management Team Changes to Accelerate Execution of Strategic Priorities
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Oct 2022
Phagenesis Launches Phagenyx Neurostimulation System in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 4 Oct 2022
Saluda Medical Appoints Laureen DeBuono to Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 3 Oct 2022
Alexion, AstraZeneca Rare Disease to Acquire LogicBio(R) Therapeutics to Accelerate Growth in Genomic Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2022
Harrow Announces U.S. FDA Approval of IHEEZO(TM) (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Sep 2022
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Sep 2022
Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Sep 2022
Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into Human Trials in Solid Tumors and Enters Cooperative Research and Development Agreement with the National Cancer Institute
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Sep 2022
Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
Devices Product Launch
 HSMN NewsFeed - 7 Sep 2022
STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 31 Aug 2022
Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to home
Devices Monitoring Distribution
 HSMN NewsFeed - 30 Aug 2022
Medtronic completes acquisition of Affera
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2022
Avenda Health Raises $10M in Series B, Innovating Detection and Treatment for Prostate Cancer Care
Devices Oncology Venture Capital
 HSMN NewsFeed - 25 Aug 2022
HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2022
3T Biosciences Debuts with $40 Million Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 19 Aug 2022
Calyptus Pharmaceuticals Announces FDA Approval of Cetrorelix Acetate for Injection, 0.25 mg/vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Aug 2022
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Aug 2022
CathVision Announces Close Of $7.2 Million Financing Round
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 12 Aug 2022
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2022
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Jul 2022
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Jul 2022
Metabolon Appoints Tom Houseman as Vice President of Operations
Biopharmaceutical Personnel
 HSMN NewsFeed - 22 Jul 2022
Published Studies Find Low Documented Adherence to Guideline-Based Care for Female Urinary Incontinence
Devices Urology
 HSMN NewsFeed - 20 Jul 2022
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
Devices Ophthalmology
 HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jul 2022
Subtle Medical Announces Partnership Expansion With Incepto
Devices Radiology
 HSMN NewsFeed - 13 Jul 2022
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2022
Accuray CyberKnife(R) System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications
Devices Oncology Neurosurgery
 HSMN NewsFeed - 11 Jul 2022
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jul 2022
Sobi to license loncastuximab tesirine from ADC Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Jul 2022
Harris Health System selects RayStation: RaySearch Laboratories
Devices Oncology
 HSMN NewsFeed - 5 Jul 2022
Former Itamar Medical CEO & President Gilad Glick Joins IceCure Medical as a Strategic Advisor for Global Go-To-Market Operations
Devices Personnel
 HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 27 Jun 2022
Centerline Biomedical Raises $33 Million in Series B Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 27 Jun 2022
Medtronic Board appoints Lidia Fonseca as a new director
Devices Personnel
 HSMN NewsFeed - 23 Jun 2022
Tryp Therapeutics Appoints New Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jun 2022
Artio Medical Closes $28M in Additional Series A Financing
Devices Venture Capital
 HSMN NewsFeed - 14 Jun 2022
Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Devices Venture Capital
 HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2022
Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand(TM) Lateral Cage as an addition to its eZspand(TM) Interbody System.
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Jun 2022
Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization
Devices Diagnostics FDA
 HSMN NewsFeed - 9 Jun 2022
Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Jun 2022
Medcura Appoints Surgical Medical Device Leader Jim Buck as New CEO
Devices Surgery Personnel
 HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 2 Jun 2022
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Devices Oncology
 HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 May 2022
Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 May 2022
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 May 2022
Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer
Devices Oncology Personnel
 HSMN NewsFeed - 13 May 2022
Medtronic completes acquisition of Intersect ENT
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 4 May 2022
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Diagnostics FDA
 HSMN NewsFeed - 27 Apr 2022
New Studies Demonstrate Clinical Benefits of Patient-and Provider-Supportive Technology in Diabetes Management
Devices Monitoring Endocrinology
 HSMN NewsFeed - 25 Apr 2022
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
Diagnostics Product Launch
 HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Devices Interventional Acquisitions
 HSMN NewsFeed - 19 Apr 2022
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2022
LTZ Therapeutics Secures $17 Million Pre-Series A Financing for Immunotherapy Development to Treat Cancer & Other Complex Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Apr 2022
FDA approves Novartis Vijoice(R) (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Apr 2022
CellCentric Strengthens Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 31 Mar 2022
10-Year Data Shows Accuray CyberKnife(R) System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
Devices Oncology
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 17 Mar 2022
Medtronic appoints new Operating Unit Presidents
Devices Personnel
 HSMN NewsFeed - 11 Mar 2022
Terran Biosciences Announces Acquisition of a Portfolio of Novel CNS Therapeutics from Concert Pharmaceuticals
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 1 Mar 2022
Visby Medical Raises over $100 Million in Series E Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 28 Feb 2022
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 28 Feb 2022
After Successful Launch of Titan SGS(R) Surgical Stapler, Standard Bariatrics, Inc. Achieves Final Series B Funding Early
Devices Surgery Venture Capital
 HSMN NewsFeed - 24 Feb 2022
Artio Medical Welcomes New R&D Leaders and Accelerates Development of Amplifi(TM) Vein Dilation System
Devices Personnel
 HSMN NewsFeed - 23 Feb 2022
Plexium Announces $102M Financing To Advance Pipeline Of Targeted Protein Degradation Therapies And Technology Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2022
Accuray TomoTherapy(R) Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
Devices Oncology
 HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 9 Feb 2022
Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix(TM) Product Platform
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 2 Feb 2022
Elekta increases customer focus with direct presence in Philippines
Devices Oncology
 HSMN NewsFeed - 1 Feb 2022
Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 1 Feb 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2022
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jan 2022
Nine Square Therapeutics Appoints Robert Paul as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jan 2022
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2022
Valo Health Names Dave Morris Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2022
Neuvivo Expands Management Team Adding Gregg Fergus, Former President of Ion Torrent, as Head of Strategy and Business Development and to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Jan 2022
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Dec 2021
Bioretec Files for CE Mark for its Bioresorbable RemeOs Magnesium Screw in the EU
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Dec 2021
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Dec 2021
Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Round
Devices Monitoring Neurosurgery Venture Capital
 HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2021
Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Dec 2021
Merck Acquires Chord Therapeutics to Expand Neuroinflammatory Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2021
Orna Therapeutics Expands Leadership Team with Key Executive Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2021
Sirius Medical Announces Second Closing of A-Round Financing
Devices Oncology Venture Capital
 HSMN NewsFeed - 14 Dec 2021
HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2021
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control(R) Platform
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2021
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Nov 2021
ViaCyte Appoints Marty Lorenzo as General Counsel
Regenerative Medicine Personnel
 HSMN NewsFeed - 29 Nov 2021
BD Names Dr. Joseph M. Smith as Chief Scientific Officer
Devices Personnel
 HSMN NewsFeed - 29 Nov 2021
HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Nov 2021
Help Therapeutics Completes Series C Financing of 25 Million Dollars
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Nov 2021
BioMarin Receives FDA Approval for VOXZOGO(TM) (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2021
Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2021
Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases
Devices Radiology FDA
 HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Devices Personnel
 HSMN NewsFeed - 12 Nov 2021
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Devices Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2021
David C. Dvorak is THINK Surgical's New Executive Chairman of the Board of Directors
Devices Orthopaedic Personnel
 HSMN NewsFeed - 9 Nov 2021
Ichnos Sciences Appoints Sonia Quaratino, M.D., Ph.D., To Its Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Nov 2021
Kintara Announces Changes to Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Nov 2021
Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2021
Michael Enxing Appointed President of PainTEQ
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 27 Oct 2021
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 27 Oct 2021
HT Supreme(R) Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2021
BD Names Dr. Carrie Byington To Board Of Directors
Devices Personnel
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Devices Oncology
 HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA
 HSMN NewsFeed - 12 Oct 2021
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Oct 2021
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
Devices Orthopaedic Dental Venture Capital
 HSMN NewsFeed - 30 Sep 2021
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 28 Sep 2021
Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Sep 2021
Boston Scientific Announces Agreement to Acquire Devoro Medical, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2021
Xenocor Expands Board of Directors to Accelerate Innovation & Launch
Devices Surgery Personnel
 HSMN NewsFeed - 17 Sep 2021
Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2021
LUMAKRAS(TM) (Sotorasib) Combined With Vectibix(R) (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2021
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
Diagnostics Personnel
 HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 9 Sep 2021
B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System
Devices Oncology Radiology
 HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2021
Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2021
Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2021
Elekta acquires Turkish distributor to strengthen market position
Devices Oncology Neurosurgery Distribution
 HSMN NewsFeed - 31 Aug 2021
New data underscores material benefits of Smith & Nephew's OXINIUM(TM) DH Technology and OR3O(TM) Dual Mobility System for total hip arthroplasty versus Cobalt Chrome liners
Devices Orthopaedic
 HSMN NewsFeed - 31 Aug 2021
Bactiguard recruits Chief Licensing Officer to accelerate growth
Devices Licensing Personnel
 HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Diagnostics FDA
 HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 27 Aug 2021
European Commission Approves BioMarin's VOXZOGO(R) (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Aug 2021
FDA Clears Thermo Scientific EliA SmD(P)-S Test For Use In U.S.
Diagnostics FDA
 HSMN NewsFeed - 18 Aug 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Aug 2021
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2021
Rigel Pharmaceuticals Provides Update on COVID-19 Program
Biopharmaceuticals
 HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Devices Surgery Venture Capital
 HSMN NewsFeed - 12 Aug 2021
Syntr Health Technologies Announces an Oversubscribed $2.2 Million Seed Round to Accelerate Market Penetration of FDA-Cleared SyntrFuge System
Devices Surgery Venture Capital Personnel
 HSMN NewsFeed - 12 Aug 2021
Syntr Health Technologies Announces FDA Clearance of the SyntrFuge System for use in Specialty Surgeries Requiring Transfer and Implantation of Patient's Own Fat Tissue
Devices Surgery FDA
 HSMN NewsFeed - 9 Aug 2021
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Aug 2021
Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(TM) Endovascular System
Devices Interventional
 HSMN NewsFeed - 3 Aug 2021
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Aug 2021
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 28 Jul 2021
Strata Oncology Completes $90 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jul 2021
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 26 Jul 2021
BlueRock Therapeutics Announces New Board Chair, New President and CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Jul 2021
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jul 2021
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 14 Jul 2021
Lilly Announces Acquisition of Protomer Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jul 2021
BD Announces Two Future Directors for Diabetes Care Spinoff Company
Devices Endocrinology Personnel
 HSMN NewsFeed - 12 Jul 2021
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jul 2021
Elekta optimizes treatment times for cancer patients via proactive service innovation
Devices Oncology
 HSMN NewsFeed - 6 Jul 2021
nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Expansion of the nanoMesh(TM) Product Line Offering to the Clinical Community
Devices Surgery Product Launch
 HSMN NewsFeed - 29 Jun 2021
FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jun 2021
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology
Devices Oncology
 HSMN NewsFeed - 25 Jun 2021
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2021
Boston Scientific Exercises Option to Acquire Farapulse, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 24 Jun 2021
Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 17 Jun 2021
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jun 2021
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
Devices Oncology FDA
 HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Jun 2021
Senda Biosciences Announces Closing of $98 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jun 2021
ViaCyte Announces Closing of $45 Million Financing to Advance Broadest Portfolio of Stem Cell-Derived Therapies for Type 1 Diabetes
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 7 Jun 2021
Elekta's new strategy to focus on growth and access to radiation therapy
Devices Oncology
 HSMN NewsFeed - 7 Jun 2021
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
Devices Oncology
 HSMN NewsFeed - 2 Jun 2021
Prytime Medical Closes Oversubscribed $6M Inside Funding Round to Fuel Commercialization Growth
Devices Venture Capital
 HSMN NewsFeed - 1 Jun 2021
100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand
Devices Oncology
 HSMN NewsFeed - 26 May 2021
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Devices Cardiology FDA
 HSMN NewsFeed - 20 May 2021
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 May 2021
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 May 2021
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 May 2021
Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder(TM) Software
Devices Orthopaedic Licensing
 HSMN NewsFeed - 6 May 2021
GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients
Diagnostics Radiology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions
 HSMN NewsFeed - 5 May 2021
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2021
Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
Diagnostics Product Launch
 HSMN NewsFeed - 3 May 2021
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Apr 2021
Olympus Launches New Line of Five Single-Use Bronchoscopes
Devices Product Launch
 HSMN NewsFeed - 30 Apr 2021
Smith & Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN(TM) LIFE Dressing
Devices Wound Care
 HSMN NewsFeed - 28 Apr 2021
Caresyntax Raises $100 Million to Make Surgery Smarter and Safer
Devices Surgery Venture Capital
 HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Apr 2021
Cardinal Health launches Outcomes(TM)
Devices Product Launch
 HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 22 Apr 2021
Accuray Receives Shonin Approval for ClearRT(TM) Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
Devices Oncology Regulatory
 HSMN NewsFeed - 20 Apr 2021
PyrAmes Raises $6 Million in Series A Financing
Devices Monitoring Cardiology Venture Capital
 HSMN NewsFeed - 19 Apr 2021
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Devices Personnel
 HSMN NewsFeed - 12 Apr 2021
Memic Innovative Surgery Raises $96 Million
Devices Surgery Venture Capital
 HSMN NewsFeed - 6 Apr 2021
nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Completion Filing of a Second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA)
Devices Surgery FDA
 HSMN NewsFeed - 6 Apr 2021
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 5 Apr 2021
IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
Devices Oncology FDA
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Celera
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!